Beyond serological classification: severe multisystem muscle involvement and fulminant dysphagia in anti-Mi-2-positive dermatomyositis.

Ajeganova S, Silva SP, Bier N, Leblanc L, Vanderhulst J, Surquin M

Open source

DOI
10.55563/clinexprheumatol/mio2xf
Published
2026 Nov 5
Container
Clinical and experimental rheumatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.55563/clinexprheumatol/mio2xf,
  title = {Beyond serological classification: severe multisystem muscle involvement and fulminant dysphagia in anti-Mi-2-positive dermatomyositis.},
  author = {Ajeganova S and Silva SP and Bier N and Leblanc L and Vanderhulst J and Surquin M},
  year = {2026},
  journal = {Clinical and experimental rheumatology},
  doi = {10.55563/clinexprheumatol/mio2xf},
  url = {https://doi.org/10.55563/clinexprheumatol/mio2xf}
}

RIS

TY  - JOUR
TI  - Beyond serological classification: severe multisystem muscle involvement and fulminant dysphagia in anti-Mi-2-positive dermatomyositis.
AU  - Ajeganova S
AU  - Silva SP
AU  - Bier N
AU  - Leblanc L
AU  - Vanderhulst J
AU  - Surquin M
PY  - 2026
JO  - Clinical and experimental rheumatology
DO  - 10.55563/clinexprheumatol/mio2xf
UR  - https://doi.org/10.55563/clinexprheumatol/mio2xf
ER  - 

APA

S, A., SP, S., N, B., L, L., J, V., & M, S. (2026). Beyond serological classification: severe multisystem muscle involvement and fulminant dysphagia in anti-Mi-2-positive dermatomyositis.. Clinical and experimental rheumatology. https://doi.org/10.55563/clinexprheumatol/mio2xf

Source records